VIDO-InterVac expands COVID-19 vaccine human clinical trials beyond Canada
VIDO-InterVac is expanding the human clinical trials of its new COVID-19 vaccine beyond Canada to other countries. The Vaccine and Infectious Disease Organization, VIDO-InterVac, received approval from Health Canada just before Christmas to begin human clinical trials of its new COVID-19 vaccine.
Posted: 06/15/2021